Gene Review:
DNAI1 - dynein, axonemal, intermediate chain 1
Homo sapiens
Synonyms:
Axonemal dynein intermediate chain 1, CILD1, DIC1, Dynein intermediate chain 1, axonemal, ICS1, ...
- Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome). Guichard, C., Harricane, M.C., Lafitte, J.J., Godard, P., Zaegel, M., Tack, V., Lalau, G., Bouvagnet, P. Am. J. Hum. Genet. (2001)
- Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease. Brandeis, W.E., Helson, L., Wang, Y., Good, R.A., Day, N.K. J. Clin. Invest. (1978)
- First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis. Leibundgut, U., Lancranjan, I. Lancet (1987)
- Loss of bone density with inhaled triamcinolone in Lung Health Study II. Scanlon, P.D., Connett, J.E., Wise, R.A., Tashkin, D.P., Madhok, T., Skeans, M., Carpenter, P.C., Bailey, W.C., Buist, A.S., Eichenhorn, M., Kanner, R.E., Weinmann, G. Am. J. Respir. Crit. Care Med. (2004)
- Effects of a 5-hydroxytryptamine3 receptor antagonist (ICS 205-930) on colonic motor activity in healthy men. Stacher, G., Gaupmann, G., Schneider, C., Stacher-Janotta, G., Steiner-Mittelbach, G., Abatzi, T.A., Steinringer, H. British journal of clinical pharmacology. (1989)
- Lack of systematic effects of the 5-hydroxytryptamine 3 receptor antagonist ICS 205-930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa. Stacher, G., Bergmann, H., Granser-Vacariu, G.V., Wiesnagrotzki, S., Wenzelabatzi, T.A., Gaupmann, G., Kugi, A., Steinringer, H., Schneider, C., Höbart, J. British journal of clinical pharmacology. (1991)
- Detailed analysis of estrous-related changes in wheel running and self-stimulation. Steiner, M., Katz, R.J., Carroll, B.J. Physiol. Behav. (1982)
- Interrater concordance for faculty grading of student performances in a problem-based learning course. Schor, N.F., Troen, P., Kanter, S.L., Janosky, J.E. Academic medicine : journal of the Association of American Medical Colleges. (1997)
- Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Pennarun, G., Escudier, E., Chapelin, C., Bridoux, A.M., Cacheux, V., Roger, G., Clément, A., Goossens, M., Amselem, S., Duriez, B. Am. J. Hum. Genet. (1999)
- Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained. de Wit, R., Schmitz, P.I., Verweij, J., de Boer-Dennert, M., de Mulder, P.H., Planting, A.S., van der Burg, M.E., Stoter, G. J. Clin. Oncol. (1996)
- Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. Alhaider, A.A., Lei, S.Z., Wilcox, G.L. J. Neurosci. (1991)
- Conserved and specific functions of axoneme components in trypanosome motility. Branche, C., Kohl, L., Toutirais, G., Buisson, J., Cosson, J., Bastin, P. J. Cell. Sci. (2006)
- Hyperalgesia due to nerve damage: role of nerve growth factor. Theodosiou, M., Rush, R.A., Zhou, X.F., Hu, D., Walker, J.S., Tracey, D.J. Pain (1999)
- Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy. Meyer, J.S., Wittliff, J.L. Int. J. Cancer (1991)
- The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndrome. Coupe, M.O., Anderson, J.V., Morris, J.A., Alstead, E.M., Bloom, S.R., Hodgson, H.J. Aliment. Pharmacol. Ther. (1988)
- Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret. Costall, B., Domeney, A.M., Naylor, R.J., Owera-Atepo, J.B., Rudd, J.A., Tattersall, F.D. Neuropharmacology (1990)
- 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis. Costall, B., Domeney, A.M., Naylor, R.J., Tattersall, F.D. Neuropharmacology (1986)
- Germline mutations in an intermediate chain dynein cause primary ciliary dyskinesia. Zariwala, M., Noone, P.G., Sannuti, A., Minnix, S., Zhou, Z., Leigh, M.W., Hazucha, M., Carson, J.L., Knowles, M.R. Am. J. Respir. Cell Mol. Biol. (2001)
- Mutations of DNAI1 in Primary Ciliary Dyskinesia: Evidence of Founder Effect in a Common Mutation. Zariwala, M.A., Leigh, M.W., Ceppa, F., Kennedy, M.P., Noone, P.G., Carson, J.L., Hazucha, M.J., Lori, A., Horvath, J., Olbrich, H., Loges, N.T., Bridoux, A.M., Pennarun, G., Duriez, B., Escudier, E., Mitchison, H.M., Chodhari, R., Chung, E.M., Morgan, L.C., de Iongh, R.U., Rutland, J., Pradal, U., Omran, H., Amselem, S., Knowles, M.R. Am. J. Respir. Crit. Care Med. (2006)
- Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects. Akkermans, L.M., Vos, A., Hoekstra, A., Roelofs, J.M., Horowitz, M. Gut (1988)
- DNA-protein interactions at the interferon-responsive promoter: evidences for an involvement of phosphorylation. Roy, C., Lebleu, B. Nucleic Acids Res. (1990)
- 5-Hydroxytryptamine facilitates cholinergic bronchoconstriction in human and guinea pig airways. Takahashi, T., Ward, J.K., Tadjkarimi, S., Yacoub, M.H., Barnes, P.J., Belvisi, M.G. Am. J. Respir. Crit. Care Med. (1995)
- Failure of tropisetron to inhibit jejunal water and electrolyte secretion induced by 5-hydroxytryptamine in healthy volunteers. Munck, L.K., Eskerod, O., Hansen, M.B., Bukhave, K., Rask-Madsen, J. Gut (1994)
- The psychopharmacology of 5-HT3 receptors. Costall, B., Naylor, R.J., Tyers, M.B. Pharmacol. Ther. (1990)
- Subdivisions of the inferior colliculus in the barn owl (Tyto alba). Knudsen, E.I. J. Comp. Neurol. (1983)
- Storage of human platelet concentrates in an artificial medium without dextrose. Adams, G.A., Rock, G. Transfusion (1988)
- Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro. Morain, P., Abraham, C., Portevin, B., De Nanteuil, G. Mol. Pharmacol. (1994)
- Purification and cDNA cloning of isochorismate synthase from elicited cell cultures of Catharanthus roseus. van Tegelen, L.J., Moreno, P.R., Croes, A.F., Verpoorte, R., Wullems, G.J. Plant Physiol. (1999)
- Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin. Cho, Y.S., Park, S.Y., Lee, C.K., Yoo, B., Moon, H.B. J. Allergy Clin. Immunol. (2003)
- Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids. Wolfe, J., Rooklin, A., Grady, J., Munk, Z.M., Stevens, A., Prillaman, B., Duke, S., Harding, S. J. Allergy Clin. Immunol. (2000)
- DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Hornef, N., Olbrich, H., Horvath, J., Zariwala, M.A., Fliegauf, M., Loges, N.T., Wildhaber, J., Noone, P.G., Kennedy, M., Antonarakis, S.E., Blouin, J.L., Bartoloni, L., Nüsslein, T., Ahrens, P., Griese, M., Kuhl, H., Sudbrak, R., Knowles, M.R., Reinhardt, R., Omran, H. Am. J. Respir. Crit. Care Med. (2006)
- Purification of the 5-hydroxytryptamine 5-HT3 receptor from NCB20 cells. McKernan, R.M., Gillard, N.P., Quirk, K., Kneen, C.O., Stevenson, G.I., Swain, C.J., Ragan, C.I. J. Biol. Chem. (1990)
- Seretide meta-analysis missed important features and overstates any advantages over concurrent LABA/ICS devices. Metcalfe, S., Moodie, P. J. Allergy Clin. Immunol. (2004)